Stories of Strength

Program Overview

Stories of Strength brings together personal stories of people living with Duchenne and healthcare providers who share their perspectives on treatment with DUVYZAT.

Learn how they overcome obstacles and embrace life with the support of their care teams and communities.

Join us for DUVYZAT Stories of Strength events!

Are you interested in hearing firsthand experiences from people living with Duchenne, along with insights from healthcare providers? Attend the latest DUVYZAT Stories of Strength events to hear their stories.

See available events >

Join us for an upcoming event featuring our DUVYZAT speakers

REGISTER NOW

Meet our DUVYZAT speakers

The following bios reflect personal experiences with DUVYZAT. Individual results with DUVYZAT may vary.

Ryan Michael C. Susan C.

Ryan Michael, living with Duchenne and taking DUVYZAT, and his mother, Susan

Seventeen-year-old Ryan Michael and his mother, Susan, share their journey of strength, advocacy, and community. Together, they inspire others through Ryan Michael’s humor and determination and Susan’s devotion as a caregiver and resource for families.

Ryan Michael, living with Duchenne and taking DUVYZAT

Ryan Michael is 17 years old and was diagnosed with Duchenne nearly a decade ago. After joining the clinical trial in 2019, he began treatment with DUVYZAT. Today, he continues to take DUVYZAT alongside steroids and heart medication, feeling positive about his care over the past 6 years.

As an ambassador for the Muscular Dystrophy Association® and active member in its Let’s Play gaming community, Ryan Michael is known for his humor, resilience, and ability to make friends with everyone he meets. He serves as his high school basketball team’s manager, is working toward becoming an Eagle Scout, and takes pride in his strong grades—especially in math.

He credits his doctor’s kindness and encouragement with making a lasting impact on his journey. Ryan Michael’s determination and infectious spirit inspire others in the Duchenne community to know they are not alone. 

All trademarks and registered trademarks are the property of their respective owners.

Susan, caregiver to Ryan Michael

Susan is a devoted mother and caregiver to her son, Ryan Michael, who was diagnosed with Duchenne when he was 8 years old. After advocating for his participation in a clinical trial, she has continued supporting him since he started treatment with DUVYZAT in 2019.

Over the years, she has become a trusted resource for other families navigating treatment and daily life with Duchenne. Susan draws strength from Ryan Michael’s determination to learn, explore, and connect with others—qualities that have helped her step out of her own introverted shell.

As his needs have evolved, she has grown stronger too, supporting him physically and emotionally through the challenges of Duchenne. Together, they stay active in the Muscular Dystrophy Association® Let’s Play online gaming community, where they connect with other families, share encouragement, and find understanding.

All trademarks and registered trademarks are the property of their respective owners.
Naythan Ethan Carlos and Gisela

Naythan and Ethan, living with Duchenne and taking DUVYZAT, and their parents, Carlos and Gisela

Brothers Naythan, 17, and Ethan, 15, have faced the challenges of Duchenne with courage and optimism, inspiring others through their determination, humor, and resilience. Alongside them, their parents, Carlos and Gisela, bring compassion, advocacy, and strength, showing how family and positivity can shine through life’s toughest challenges.

Naythan, living with Duchenne and taking DUVYZAT

Naythan is 17 years old and was diagnosed with Duchenne at age 3. He began treatment with DUVYZAT in 2016 after participating in the clinical trial with his younger brother, Ethan.

Naythan has shown courage and determination while navigating the challenges of living with Duchenne. In his free time, he enjoys hanging out with his friends and family. Naythan’s journey reflects his strength beyond his physical abilities as his hopeful outlook uplifts his siblings and everyone around him.

Ethan, living with Duchenne and taking DUVYZAT

Ethan is 15 years old and was diagnosed with Duchenne at 18 months old. He began treatment with DUVYZAT in 2016 after participating in the clinical trial with his older brother, Naythan.

Known for his love of science and quick curiosity, Ethan excels in his homeschool studies and tackles challenges with a positive spirit. Despite mobility limitations, he continues to surprise his family with his perseverance, like the time he climbed a mountain in Peru on his hands and knees. Ethan has grown into a determined and resilient young man. His strength, humor, and optimism inspire everyone around him.

Carlos and Gisela, caregivers to Naythan and Ethan

Carlos and Gisela are dedicated parents and caregivers to their sons, who were diagnosed with Duchenne at just 18 months and 3 years old. Since 2016, their boys have been treated with DUVYZAT, corticosteroids, and other medications.

Gisela’s journey with Duchenne began at a young age when her cousin and brothers were diagnosed. That early experience shaped the strength and resilience she carries today as a mother. Alongside her, Carlos draws on his background as a registered nurse and healthcare executive, serving as a tireless advocate for their children.

Together, they’ve navigated clinical trials, insurance hurdles, and the daily realities of caregiving, always working to ensure their children receive the best possible care. Through their unwavering positivity and determination, Carlos and Gisela show their children that joy can outshine even life’s toughest challenges.

Conner Jessica

Conner, living with Duchenne and taking DUVYZAT, and his mother, Jessica

Fourteen-year-old Conner, who was diagnosed with Duchenne at age 4, brings determination, humor, and big dreams to everything he does. By his side, his mother, Jessica, is a caregiver and champion, supporting his journey while raising awareness so kids like Conner feel seen and understood.

Conner, living with Duchenne and taking DUVYZAT

Conner is a 14 year old living with the diagnosis of Duchenne since he was 4. For much of that time, his treatment options were limited to steroids—until he discovered DUVYZAT in 2024, bringing new hope to him and his family.

Every day, Conner faces the challenges of Duchenne with remarkable strength and determination. He uses an electric scooter to get around, but it’s his adventurous spirit that truly moves him forward. A huge sports fan, Conner has set an ambitious goal: to visit all 30 Major League Baseball (MLB) stadiums across the country—he’s already made it to 16!

Although he can’t always join in on school sports, Conner finds joy in cooking with his parents and playing chess and video games with his friends. His story is a powerful reminder that life will throw curveballs—it’s how we step up to the plate that matters most.

Jessica, caregiver to Conner

Jessica is a teacher, devoted mother, and caregiver to her son, Conner. He was diagnosed with Duchenne at just 4 years old.

Since starting DUVYZAT, Conner’s doctors have continued to evaluate his progress. Jessica partners closely with them to ensure her son stays on treatment. Beyond helping to manage Duchenne, Jessica encourages Conner’s dream of visiting all 30 MLB stadiums. She describes him as an all-around American teen—he loves football, eating wings, and playing football video games. As a family, Conner and his parents love to cook together and invent exciting new recipes.

Jessica is by Conner’s side through the ups and downs of daily life. Although Jessica sees how strong Conner can be, she’s also there to support him in the more difficult moments. Conner cannot participate in physical activities, including sports, and sometimes feels embarrassed when using his electric scooter. Jessica knows these moments can be tough, and they work through them together. She recognizes the challenges of navigating a world that doesn’t always understand disability, and she hopes their story will raise awareness of Duchenne so that other kids like Conner can feel seen and understood. 

Grant Leslie

Grant, living with Duchenne and taking DUVYZAT, and his mother, Leslie

Fourteen-year-old Grant is known for his kindness and curiosity as he navigates life with Duchenne. His mother, Leslie, left her career as an attorney to be his full-time caregiver and advocate, using her determination to support both her son and the broader Duchenne community.

Grant, living with Duchenne and taking DUVYZAT

Grant, 14, was diagnosed with Duchenne in 2016. He has had treatment with DUVYZAT since early 2025 and currently takes it alongside corticosteroids and other medications.

Affectionately known as “Saint Grant” by his family, Grant is the embodiment of empathetic kindness and courage. He fills his free time playing video games, learning about animals, and exploring stories from history—always bringing warmth and curiosity to everything he does.

Leslie, caregiver to Grant

Leslie is mother and caregiver to her son, Grant, who was diagnosed with Duchenne when he was 5 years old.

Since Grant began treatment with DUVYZAT in 2025, Leslie has been by his side every step of the way. After building a career as an attorney and working as a state prosecutor, she chose to become a stay-at-home mom and caregiver—bringing her fierce determination and advocacy skills to her family’s journey with Duchenne.

Leslie has faced the challenges of navigating insurance and accessing essential treatments firsthand, ensuring Grant receives the care and resources he needs. Beyond her own family, Leslie has made a difference in the broader Duchenne community, working with advocacy groups and connecting families with vital support and resources.

Joe Rosalia and Richard

Joe, living with Duchenne and taking DUVYZAT, and his parents, Rosalia and Richard

Eight-year-old Joe faces Duchenne with determination, optimism, and a love for gaming and family time. Alongside him, his parents, Rosalia and Richard, balance caregiving and advocacy—working to expand legislation for newborn screening and showing that joy and perseverance define their family’s relationship and journey.

Joe, living with Duchenne and taking DUVYZAT

Joe is an 8 year old with Duchenne. He was diagnosed at age 5 and began treatment with DUVYZAT in 2024. He currently takes DUVYZAT alongside a novel corticosteroid and an ACE inhibitor. Known for his empathy, resilience, and positivity, Joe’s mom, Rosalia, says he is “the most happy-go-lucky kid.” Joe is in the third grade and enjoys gaming and spending time with his family.

Rosalia and Richard, caregivers to Joe

Rosalia and Richard are devoted parents and caregivers to their son, Joe. They learned about DUVYZAT from another family whose son was on treatment.

Rosalia has become an advocate for not only her son, but families living with Duchenne across the nation. She has helped pass legislation in her state that ensures every newborn is screened for Duchenne. Today, she is working to pass that same legislation at the federal level. Through her advocacy, she continues to raise awareness, connect families with resources, and inspire hope for the Duchenne community.

Richard supports Joe both physically and emotionally—carrying Joe and lifting his spirits when needed. For Richard, being a steady source of strength is just as important as maintaining a hopeful outlook for the future.

Together, Rosalia and Richard balance advocacy and everyday caregiving as a unit. For them, it’s important to show Joe that while Duchenne is a part of their lives, it does not define their lives or overshadow the joy their family shares.

Sign up for upcoming events

Hear from Jessica & Dr. Perry Shieh, MD, PhD, FAAN

Join us for the DUVYZAT Stories of Strength event to hear from Dr. Perry Shieh, MD, PhD, FAAN and a Duchenne muscular dystrophy (DMD) caregiver, Jessica. Sheih will share his experience with DMD, the diagnosis process, his approaches to treatment, and an overview of DUVYZAT. Jessica, Connor's primary caregiver, will share her experience with Duchenne and DUVYZAT, along with helpful resources and community support networks. Don’t miss this opportunity to connect with those living with and treating Duchenne!
Name: Jessica & Dr. Perry Shieh, MD, PhD, FAAN
Stories of Strength
12/08/2025 4:00 PM EST
Register for this event
More than 1000 people with Duchenne are currently being treated with DUVYZAT. Data as of July 2025.
Stories of Strength

Hear from people living with Duchenne and from healthcare providers at our DUVYZAT Stories of Strength events.

HEAR THEIR STORIES

Important Safety Information

What is the most important information I should know about DUVYZAT?

  • Low platelet counts in your blood (thrombocytopenia). Platelets are important for blood clotting, so having fewer can increase your risk of bleeding or bruising. Your doctor will check your blood count before you start DUVYZAT and regularly during treatment for signs of thrombocytopenia. Call your doctor right away if you notice unusual bleeding or small red or purple spots on the skin.
  • Increased levels of fat (triglycerides) in your blood. You may not have any symptoms, so your doctor will do blood tests before you start DUVYZAT and regularly during treatment to check your triglyceride levels.
  • Frequent watery loose stools (diarrhea) and vomiting. DUVYZAT can cause vomiting and moderate to severe diarrhea. If diarrhea occurs, you should keep track of the frequency and severity of your diarrhea symptoms, drink plenty of fluids, and contact your doctor.
  • If thrombocytopenia, increased triglycerides, or diarrhea cannot be managed, your doctor may change your dose or stop your treatment with DUVYZAT, if needed.

Before taking DUVYZAT, tell your doctor about all of your medical conditions, including:

  • any heart problems or medicines you take that could increase your chance for irregular heart rhythms.
  • any bleeding problems.

Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Taking DUVYZAT with certain other medicines may affect each other. Taking DUVYZAT with other medicines can cause serious side effects. Do not start or stop other medicines without talking to your doctor.

What are the possible side effects of DUVYZAT?

  • DUVYZAT can cause serious side effects, including changes in the electrical activity of your heart called QT prolongation. QT prolongation can increase the risk of developing a type of irregular heart rhythm known as Torsades de Pointes. Call your doctor right away if you feel faint, have an irregular heartbeat, feel dizzy, or lose consciousness. See the section titled “What is the most important information I should know about DUVYZAT?” for more information about side effects.

The most common side effects (occurring in >5% of DUVYZAT-treated patients) included diarrhea, abdominal pain, low platelet levels, nausea/vomiting, high triglyceride levels, elevated temperature/fever, muscle aches, rash, joint pain, fatigue, constipation and decreased appetite.

These are not all of the possible side effects of DUVYZAT. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is DUVYZAT?

DUVYZAT is a prescription medicine for the treatment of Duchenne muscular dystrophy (DMD) in people 6 years of age and older. It is not known if DUVYZAT is safe and effective in children under age 6.

Please see full Prescribing Information and Medication Guide.
More than 1000 people with Duchenne are currently being treated with DUVYZAT. Data as of July 2025.
Stories of Strength

Hear from people living with Duchenne and from healthcare providers at our DUVYZAT Stories of Strength events.

HEAR THEIR STORIES

Important Safety Information

What is the most important information I should know about DUVYZAT?

  • Low platelet counts in your blood (thrombocytopenia). Platelets are important for blood clotting, so having fewer can increase your risk of bleeding or bruising. Your doctor will check your blood count before you start DUVYZAT and regularly during treatment for signs of thrombocytopenia. Call your doctor right away if you notice unusual bleeding or small red or purple spots on the skin.
  • Increased levels of fat (triglycerides) in your blood. You may not have any symptoms, so your doctor will do blood tests before you start DUVYZAT and regularly during treatment to check your triglyceride levels.
  • Frequent watery loose stools (diarrhea) and vomiting. DUVYZAT can cause vomiting and moderate to severe diarrhea. If diarrhea occurs, you should keep track of the frequency and severity of your diarrhea symptoms, drink plenty of fluids, and contact your doctor.
  • If thrombocytopenia, increased triglycerides, or diarrhea cannot be managed, your doctor may change your dose or stop your treatment with DUVYZAT, if needed.

Before taking DUVYZAT, tell your doctor about all of your medical conditions, including:

  • any heart problems or medicines you take that could increase your chance for irregular heart rhythms.
  • any bleeding problems.

Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Taking DUVYZAT with certain other medicines may affect each other. Taking DUVYZAT with other medicines can cause serious side effects. Do not start or stop other medicines without talking to your doctor.

What are the possible side effects of DUVYZAT?

  • DUVYZAT can cause serious side effects, including changes in the electrical activity of your heart called QT prolongation. QT prolongation can increase the risk of developing a type of irregular heart rhythm known as Torsades de Pointes. Call your doctor right away if you feel faint, have an irregular heartbeat, feel dizzy, or lose consciousness. See the section titled “What is the most important information I should know about DUVYZAT?” for more information about side effects.

The most common side effects (occurring in >5% of DUVYZAT-treated patients) included diarrhea, abdominal pain, low platelet levels, nausea/vomiting, high triglyceride levels, elevated temperature/fever, muscle aches, rash, joint pain, fatigue, constipation and decreased appetite.

These are not all of the possible side effects of DUVYZAT. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Indication

What is DUVYZAT?

DUVYZAT is a prescription medicine for the treatment of Duchenne muscular dystrophy (DMD) in people 6 years of age and older. It is not known if DUVYZAT is safe and effective in children under age 6.

Please see full Prescribing Information and Medication Guide.